Advisory Board February 5, 2025

On Monday, FDA granted two biotechnology companies approval for clinical trials that will transplant genetically modified pig organs into patients with kidney failure — an experimental method that could potentially change the lives of thousands of Americans waiting for a limited number of human organs.

5 key tactics to attract and retain transplant patients

The growing field of xenotransplantation

Currently, there are over 106,000 people on the national list for organ transplants in the United States, with many of them looking for kidney transplants. However, there is a significant shortage of available organs. In 2023, only 27,000 kidney transplants were performed.

In recent years, scientists have been working to advance the field of xenotransplantation, or the transplanting of an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, FDA, Govt Agencies, Provider, Trends
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
FDA Approves Third Tocilizumab Biosimilar
The Biden Administration’s Swan Song on Digital Health: Two FDA Guidances on Artificial Intelligence and FDA’s Defense of its Clinical Decision Support Guidance
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown

Share This Article